Precision BioSciences (DTIL) stock saw a 31% premarket surge after positive results from its gene therapy trial for treating ...

Annovis Bio (ANVS) stock slipped after the company said the FDA accepted its updated protocol for a Phase 3 trial for its ...

Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative ...

Nuvie Bio, a new clinical-stage biopharmaceutical company dedicated to addressing the most pressing unmet medical needs in migraine and related neurological diseases, announced completion of a ...

ASN-008 is under clinical development by Formation Bio and currently in Phase II for Notalgia Paresthetica. According to GlobalData, Phase II drugs for Notalgia Paresthetica does not have sufficient ...

New Delhi: Prime Minister Narendra Modi on Thursday released the genome sequencing data of 10,000 Indian nationals.

ASN-008 is under clinical development by Formation Bio and currently in Phase II for Pruritus. According to GlobalData, Phase II drugs for Pruritus have a 50% phase transition success rate (PTSR) ...

By bridging the gap between immersive technology and user-centric design, this research paves the way for a future where VR’s ...

Variant Bio is partnering with Novo Nordisk to study metabolic diseases including obesity, using Variant's genomic data from ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Prime Minister Narendra Modi said on Thursday that the combination of biotechnology and biomass is an important part of the ...

Novo Nordisk will provide Variant with an upfront payment and additional near-term R&D funding that could reach up to $50m.